Navigation Links
Transgenomic, Inc. Reports Second Quarter 2007 Results
Date:8/19/2007

vents and performance to differ materially from those referred to in such statements. Accordingly, the company claims the protection of the safe harbor for forward-looking statements contained in the Private Securities Litigation Reform Act of 1995 with respect to all statements contained in this press release. All information in this press release is as of the date of the release and Transgenomic does not undertake any duty to update this information, including any forward-looking statements, unless required by law.

Transgenomic, Inc.

Summary Financial Results

Unaudited Condensed Consolidated Statements of Operations

(dollars in thousands except per share data)

Three Months Six Months

Ended Ended

June 30 June 30

2007 2006 2007 2006

NET SALES $6,272 $6,189 $11,494 $12,686

COST OF GOODS SOLD 2,859 3,140 5,373 6,654

Gross profit 3,413 3,049 6,121 6,032

OPERATING EXPENSES:

Selling, general and

administrative 3,067 2,820 6,047 5,529

Research and development 492 531 1,550 1,135

Restructuring costs 624 -- 624 --

4,183 3,351 8,221 6,664

LOSS FROM OPERATIONS (770) (302) (2,100) (632)

OTHER INCOME (EXPENSE):

Interest income, net of

interest expense 79 44 141 88

Other, net -- -- 4 --

Gain on sale of i
'/>"/>

SOURCE Transgenomic, Inc.

Copyright©2007 PR Newswire.

0

GOOD

Page: 1 2 3 4 5 6 7 8

Related biology technology :

1. TomoTherapy reports 86% revenue jump, $131M net loss in Q1
2. Sonic Foundry reports GAAP loss as Q2 revenues rise
3. Fiserv reports $113.5 million in Q1 profit
4. Third Wave reports net loss of $18.9M for 2006
5. Musicnotes reports 45 percent growth in 2006
6. Sonic Foundry reports net loss, higher revenue
7. Sonic Foundry reports first cash-positive quarter
8. Merge Healthcare reports $10.8M net loss in Q3
9. Third Wave reports $5.2M third quarter loss
10. Merge Healthcare appoints new CEO, reports $215 million Q2 loss
11. Merge files financial reports by market opening
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/14/2009)... WALTHAM, Mass., Dec. 14 Decision Resources, ... firms for pharmaceutical and healthcare issues, finds that, ... the atrial fibrillation drug market will increase more ... $6.1 billion in 2018 in the United States, ... Japan. ,, The new Pharmacor report entitled ...
(Date:12/11/2009)... SEATTLE, Dec. 11 Dendreon Corporation (Nasdaq: ... of its previously announced public offering have exercised ... 2,250,000 shares of common stock at the public ... exercise of the option increases the size of ... of common stock. Dendreon expects to receive ...
(Date:12/11/2009)... 11 Ambit Biosciences Corporation announced today the ... D. Anderson Cancer Center of the first patient in ... E fficacy) Phase 2 pivotal trial in ... AC220 is a novel, orally available, potent and ... a FMS-like tyrosine kinase-3 (FLT3) inhibitor. The ACE ...
(Date:12/11/2009)... CALGARY, Dec. 11 /PRNewswire-FirstCall/ - Oncolytics Biotech Inc. ... today announced the appointment of Dr. Alan Warrander ... Licensing and Business Development. ,, "Dr. Warrander will ... licensing strategy for REOLYSIN(R)," said Dr. Brad Thompson, ... agreement on the design of a Phase 3 ...
Breaking Biology Technology:The Atrial Fibrillation Drug Market Will Increase More Than Sevenfold, from $790 Million in 2008 to $6.1 Billion in 2018 2Dendreon Announces Exercise of Option by Underwriters in its Common Stock Offering 2Dendreon Announces Exercise of Option by Underwriters in its Common Stock Offering 3Ambit Biosciences Initiates First Phase 2 Clinical Trial of AC220 in Acute Myeloid Leukemia 2Ambit Biosciences Initiates First Phase 2 Clinical Trial of AC220 in Acute Myeloid Leukemia 3Ambit Biosciences Initiates First Phase 2 Clinical Trial of AC220 in Acute Myeloid Leukemia 4Ambit Biosciences Initiates First Phase 2 Clinical Trial of AC220 in Acute Myeloid Leukemia 5Oncolytics Biotech(R) Inc. Appoints Senior Vice President, Global Licensing and Business Development 2Oncolytics Biotech(R) Inc. Appoints Senior Vice President, Global Licensing and Business Development 3
... Parion Sciences, Inc. today announced,that its partner, Gilead ... a Phase I,clinical trial of GS9411 in healthy ... investigational compound. GS9411 is designed to increase,airway ... Previously known as,P-680, GS9411 is an epithelial sodium ...
... its revolutionary Trusted LASIK Surgeons directory service and website ... resource for consumers seeking to improve their vision. What ... unique screening process ensuring that only those who are ... eye surgery in the United States are listed. ...
... the well-known dangers of first- and secondhand smoke, an estimated ... Exposure of a developing baby to harmful cigarette byproducts ... year and poses a significant health care burden. , Now, ... researchers has completed a global assessment of newborns, umbilical cord ...
Other Biology Technology:Parion Sciences Announces Initiation of Phase I Clinical Trial to Evaluate Safety and Tolerability of GS9411 2Parion Sciences Announces Initiation of Phase I Clinical Trial to Evaluate Safety and Tolerability of GS9411 3Houston LASIK Eye Surgery Expert and Pioneer Jack Holladay, M.D. Joins Influential Group of Eye Surgeons Listed at Trusted LASIK Surgeons 2Houston LASIK Eye Surgery Expert and Pioneer Jack Holladay, M.D. Joins Influential Group of Eye Surgeons Listed at Trusted LASIK Surgeons 3Houston LASIK Eye Surgery Expert and Pioneer Jack Holladay, M.D. Joins Influential Group of Eye Surgeons Listed at Trusted LASIK Surgeons 4Houston LASIK Eye Surgery Expert and Pioneer Jack Holladay, M.D. Joins Influential Group of Eye Surgeons Listed at Trusted LASIK Surgeons 5Houston LASIK Eye Surgery Expert and Pioneer Jack Holladay, M.D. Joins Influential Group of Eye Surgeons Listed at Trusted LASIK Surgeons 6Houston LASIK Eye Surgery Expert and Pioneer Jack Holladay, M.D. Joins Influential Group of Eye Surgeons Listed at Trusted LASIK Surgeons 7Cutting the cord to determine babies' health risk from toxic exposure 2Cutting the cord to determine babies' health risk from toxic exposure 3Cutting the cord to determine babies' health risk from toxic exposure 4
(Date:12/15/2009)... is a standard laboratory model organism, but there ... to analyze blood and blood-forming tissues in this ... and easy-to-use laboratory resources from Cold Spring Harbor ... Hematology features step-by-step protocols for the preparation, ... marrow, and other hematopoietic tissues in the mouse. ...
(Date:12/14/2009)... in a freeze-tolerant Alaska beetle able to survive temperatures ... biological antifreezes that contain protein, this new molecule, called ... of a sugar and a fatty acid and may ... , "The most exciting part of this discovery ... of antifreeze that may work in a different location ...
(Date:12/14/2009)... The most comprehensive study to date of the proteins ... may provide important clues to how similar regeneration could ... School of Science at Indiana University-Purdue University Indianapolis and ... limbs of axolotls, a type of salamander that has ... level of amputation, with the hope that this knowledge ...
Breaking Biology News(10 mins):New source of classical techniques for blood-based studies in the laboratory mouse 2Scientists isolate new antifreeze molecule in Alaska beetle 2IUPUI researchers tackle protein mechanisms behind limb regeneration 2IDRI to Use NanoPass Microneedle Technology for Intradermal Vaccines and Diagnostic Skin Tests 55679 1IDRI to Use NanoPass Microneedle Technology for Intradermal Vaccines and Diagnostic Skin Tests 55679 2Former Veterans Affairs Secretary Joins Integrated Medical Systems Advisory Board 55676 1Former Veterans Affairs Secretary Joins Integrated Medical Systems Advisory Board 55676 2Former Veterans Affairs Secretary Joins Integrated Medical Systems Advisory Board 55676 380 Million European Runners Reveal Their Reasons to Run 55673 180 Million European Runners Reveal Their Reasons to Run 55673 280 Million European Runners Reveal Their Reasons to Run 55673 3
... respected as a world leader in scientific research, has ... being filled by foreign guest workers, but recent regulations ... S. have created a need for a new pool ... his colleagues at Texas A&M UniversityKingsville, the University of ...
... vegetables and fruits, color is one of the best ... color plays an important role in the business of ... example, color and color uniformity contribute directly to quality ... YSD, a ripening disorder that results in blotchy discoloration ...
... almost half as much particulate pollution into the air ... a new study. Ship pollutants affect both the Earth,s ... , The study is the first to provide ... air particle pollution based on direct measurements of emissions. ...
Other Biology News:Science internships attract students to research careers 2Color test enhances tomato analyzer software 2Commercial ships spew half as much particulate pollution as world's cars 2Commercial ships spew half as much particulate pollution as world's cars 3
Ly-49C and Ly-49I Biotin Anti-Mouse clone 5E6, Isotype Mouse IgG 2a , kappa, 0.1 mg Consult technical datasheet for details....
Mouse monoclonal [M7-PB-E9] to pan alpha Sodium Potassium ATPase ( Abpromise for all tested applications)....
Gentamicin sulfate, 5g...
Rabbit Anti-melatonin (different linkage) Polyclonal Antibody...
Biology Products: